Richer real world data insights can drive smarter decisions.


With an established healthcare system and non-restrictive patient access to medicines, Japan is currently the third largest pharmaceutical market in the world – and the second ranked country by protected pharmaceutical brand spend. IQVIA technology and Japanese Real World Data, help you rapidly identify emerging healthcare trends, inform drug development decisions, and clearly define the treatment journey to prove the value of your products over competitors, across numerous therapies, use cases, and markets.
We’d love to show you how IQVIA can help you rapidly identify the right Real World Data before licencing.
Tell us a little about your business needs and we'll connect you with a dedicated expert who can share more about our product solutions and answer any questions you have.
Richer real world data insights can drive smarter decisions.
See how we bring together global data assets, AI-powered analytic solutions, and industry-leading healthcare expertise